Similar Search Results

Narrow search

Interfirm heterogeneity in the performance of mid-sized companies in the German pharmaceutical industry

Ammer, Richard - 2006

Persistent link: https://www.econbiz.de/10003313573

Präventives Konfliktmanagement : am Beispiel von F&E Kooperationen zwischen Pharma- und Biotechnologieunternehmen

Schmidt, Daniel F. - 2006 - 1. ed.

Persistent link: https://www.econbiz.de/10003339079

Industria farmacéutica y propiedad intelectual : los países en desarrollo

Guzmán, Alenka (contributor); … - 2005 - 1. ed

Persistent link: https://www.econbiz.de/10003335558

L ́Europe du médicament : politique, expertise, intérêts privés

Hauray, Boris - 2006

Persistent link: https://www.econbiz.de/10003317153

Technological diversity and future product diversity in the drug industry

Cantner, Uwe; Plotnikova, Tatiana - 2009

This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the diversity of a firm's product portfolio. More specifically, we try to explain large firms' expansion into new product markets driven by the characteristics of their technological...